Hernández-del Río JE

Language: Spanish
References: 12
Page: 25-29
PDF size: 586.55 Kb.

ABSTRACT

Introduction. Left ventricular hypertrophy (LVH) is a frequent finding in patients with hypertension and it may be diagnosed with electrocardiography or echocardiography. The last one may be the best, since electrocardiogram criteria has a sensitivity of 7 to 35% in patients with mild disease and 10 to 40% in those with moderate to severe variations. The increase of heart risk associated with LVH is probable due to myocardial ischemia produced by various factors. One of them is the decrease in capillary density of hypertrophic myocardium. Myocardial hypertrophy can be determined by ecocardiography and ir it is an early sign organ damage. This is correlated higher cardiovascular, so we must consider if this procedure must be done in patients with hypertensions or with cardiovascular risk factors. To evaluate the left ventricular mass, as well as the evidence of LVH using echocardiography in patients with ischemic vascular events.
Material y Methods. We performed a retrospective, descriptive transversal study to investigate incidence of left ventricular hypertrophy in patients with ischemic vascular events. W also looked for associations of these events with shunts, valvulpathies, thrombi or intracavitary masses and endocarditis. Cardiovascular risk was determined using Framingham, SCORE and NIHSS scores. This was done between march 2011 and march 2012, in patients with ischemic vascular events hospitalized in internal medicine, geriatrics and cardiology of the Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde.
Results. A total of 100 patients were enrolled. We found a greater incidence of LVH in 72%. There was a positive relation between left ventricular mass and cardiovascular risk according to the Framingham, SCORE and NIHSS scales, as well as with neurological deficit. Discussion. There is a clear association between left ventricular hypertrophy and ischemic vascular events. LVH determined by echocardiogram is an early sign of organ damage and it is closely related to a greater cardiovascular risk and a higher neurological deficit. Its association with other risk factors like auricular dilation and atrial fibrillation also raise the issue of echocardiography should be done in patients with hypertension and cardiovascular risk factors

REFERENCES

1. 1.Levy, D, Garrison, RJ, Savage, DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561.

2. 2.Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension; Ann Intern Med. 1991;114(5):345.

3. 3.Elias MF, Sullivan LM, Elias PK, et al. Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring. Hypertension 2007; 49:439.

4. 4.Rials SJ, Wu Y, Xu X, Filart RA, Marinchak RA, Kowey PR; Regression of left ventricular hypertrophy with captopril restores normal ventricular action potential duration, dispersion of refractoriness, and vulnerability to inducible ventricular fibrillation; Circulation. 1997;96(4):1330.

5. 5.Lang RM, et al; Recommendations for chamber quantification; J Am Soc Echocardiogr 2005; 18:1454-7.

6. 6.Devereux RB, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.

7. 7.Abhayatna Wp, Seward JB, Appleton CP et al. Left atrial size: physiologic determinants and clinical applications. Jam Col Cardiol 2006; 47:2357-63.

8. 8.Gilon G, Buonenno F, Jotte M, et al; Lack of an association between valve prolapsed and stroke in young patients. N Eng J Med 1999;341:8-13.

9. 9.Daniel WG, Nellessen U, et al; Left atrial spontaneous echo contrast in mitral valve disease: an indicator for an increased thromboembolic risk. J Am Coll Cardiol 1988;11: 1204-11.

10. 10.Furlan, A, Reisman M, Massaro, et al; Closure or medical therapy for cryptogenic stroke with patent foramen oval; N Engl J Med 2012;366:991-9.

11. 11.Meier B. PC Trial update: Late-breaking trial preview. TCT 2012; October 25, 2012; Miami, FL.

12. 12.Carrol JD. RESPECT: Late-breaking trial preview. TCT 2012; October 25, 2012; Miami FL.